NewAmsterdam Pharma Company N.V. (NAMS) reported Q1 Revenue

Go back to NewAmsterdam Pharma Company N.V. (NAMS) reported Q1 Revenue
NAMSCO Corporation (NASDAQ: NAMS) Delayed: 25.44 -0.41 (1.59%)
Previous Close $25.85    52 Week High $0.00 
Open $25.65    52 Week Low $0.00 
Day High $25.75    P/E N/A 
Day Low $25.10    EPS $0.00 
Volume 287,449